Ezetimibe Tablet
Product Images NDC 68382-773

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 68382-773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ezetimibe Tablets, 10 mg (F94b0d30 9b8a 4ec4 A185 6b817b68809f 01)

Chemical structure diagram of ezetimibe, showing its molecular arrangement including aromatic rings, hydroxyl groups, sulfur atom, and fluorine substitutions as depicted in the image.*

FDA Label Image

Ezetimibe Tablets, 10 mg (F94b0d30 9b8a 4ec4 A185 6b817b68809f 02)

Ezetimibe Tablets USP 10 mg oral tablet carton label from Zydus Pharmaceuticals USA Inc. The label shows the tablet imprint "773" and indicates a quantity of 30 tablets with prescription-only status. Additional details include storage instructions and manufacturer information for Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.